Skip to content
DraconiticResearch
Search Sources API
220,620 studies31 sourcesUpdated 48 min ago
PreprintCC BY-NC-NDbioRxiv

Brain proteinopathies associated physiological changes leading to cognitive resilience in Alzheimer's disease

  1. 1Purdue University

Abstract

Alzheimer's disease (AD) pathology has been well characterized, however the molecular mechanisms underlying resilience to the disease remain understudied. With the growing evidence of individuals who are resilient to AD and generation of cross-cohort multiomics data, it has become feasible to understand these mechanisms. In this study, we integrated longitudinal cognitive assessments, regional neuropathology, and matched prefrontal proteomic and metabolomic profiles across donors from two independent cohorts. We identified that asymptomatic AD (AsymAD) brains exhibited amyloid burdens comparable to AD but had fewer compact plaques, lower regional tau burden, and more restricted TDP-43 pathology. Across matched stages of amyloid, tau, and TDP-43 pathology, AsymAD was consistently distinguished from AD by preservation of mitochondrial translation and bioenergetics, synaptic programs, glutamatergic metabolites, and polyunsaturated membrane lipids. Longitudinal cognitive assessments further separated resilient from vulnerable AsymAD individuals despite comparable amyloid and TDP-43 burden, with vulnerability associated with greater neurofibrillary tangle accumulation. Both AsymAD groups retained a prefrontal proteome close to that of cognitively normal individuals, apart from amyloid-associated proteins, whereas mitochondrial, synaptic, and immune changes were largely confined to AD.

Related

  1. Concurrent cognitive, behavioral and systemic physiological features mark preclinical Alzheimer's disease
    L. Tsoran, Y. Rom, A. Taha +8
    bioRxivPreprintCC BY-NC-NDFull textNeurosciencebioRxiv
  2. A Multi-Omics Study of Cognitive Resilience to Alzheimer's Disease
    E. Wang, B. Xie, M. Wang +14
    bioRxivPreprintCC BY-NC-NDFull textGenetics & genomicsbioRxiv
  3. Stable neuronal representations underlie cognitive resilience to Alzheimer's disease pathology
    Keying Chen, Emma Pineau, Margaret M. Koletar +7
    Alzheimer s & DementiaPeer-reviewedCC BY-NC-ND5 citedNeuroscienceOpenAlex
  4. The effects of Arf4 gene knockdown on Alzheimer's amyloid β deposition: Possible role in cognitive resilience
    Sara Hemmati, Erming Wang, Minghui Wang +9
    Research SquarePreprintCC BY 4.0Full textNeurosciencePMC
  5. Integrated characterization of terminal heat stress resilience in linseed through agronomic, reproductive, and physiological responses
    Md Sabir Ahmed Mondol, Soumen Bera, Suvendu Mondal +5
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textPlant biologyCrossref
BibTeX
@misc{mandal2026brain,
  title = {{Brain proteinopathies associated physiological changes leading to cognitive resilience in Alzheimer's disease}},
  author = {P. Mandal and P. Baloni},
  howpublished = {bioRxiv},
  year = {2026},
  month = nov,
  doi = {10.64898/2026.11.09.765496},
  url = {https://www.biorxiv.org/content/10.64898/2026.11.09.765496v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Brain proteinopathies associated physiological changes leading to cognitive resilience in Alzheimer's disease
AU  - P. Mandal
AU  - P. Baloni
PY  - 2026
DA  - 2026/11/09
PB  - bioRxiv
DO  - 10.64898/2026.11.09.765496
UR  - https://www.biorxiv.org/content/10.64898/2026.11.09.765496v1
AB  - Alzheimer's disease (AD) pathology has been well characterized, however the molecular mechanisms underlying resilience to the disease remain understudied. With the growing evidence of individuals who are resilient to AD and generation of cross-cohort multiomics data, it has become feasible to understand these mechanisms. In this study, we integrated longitudinal cognitive assessments, regional neuropathology, and matched prefrontal proteomic and metabolomic profiles across donors from two independent cohorts. We identified that asymptomatic AD (AsymAD) brains exhibited amyloid burdens comparable to AD but had fewer compact plaques, lower regional tau burden, and more restricted TDP-43 pathology. Across matched stages of amyloid, tau, and TDP-43 pathology, AsymAD was consistently distinguished from AD by preservation of mitochondrial translation and bioenergetics, synaptic programs, glutamatergic metabolites, and polyunsaturated membrane lipids. Longitudinal cognitive assessments further separated resilient from vulnerable AsymAD individuals despite comparable amyloid and TDP-43 burden, with vulnerability associated with greater neurofibrillary tangle accumulation. Both AsymAD groups retained a prefrontal proteome close to that of cognitively normal individuals, apart from amyloid-associated proteins, whereas mitochondrial, synaptic, and immune changes were largely confined to AD.
ER  -